Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma
Academic and Community Cancer Research United
Academic and Community Cancer Research United
University of Nebraska
National Institutes of Health Clinical Center (CC)
Universität des Saarlandes
SWOG Cancer Research Network
SWOG Cancer Research Network
Alliance for Clinical Trials in Oncology
Hoag Memorial Hospital Presbyterian
Northwestern University
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Heidelberg University
Corixa Corporation